Dicloran Injection

Dicloran Injection

diclofenac

Manufacturer:

Unique Pharma Lab

Distributor:

Unimed
Concise Prescribing Info
Contents
Diclofenac Na
Indications/Uses
Acute, severe pain due to inflammatory & degenerative form of rheumatism, RA, ankylosing spondylitis, OA. Post-traumatic pain, inflammation & swelling; pain following dental surgery. Acute gout attack.
Dosage/Direction for Use
IM Adult 1 amp daily, may be increased to 2 amp for severe cases. Max: 150 mg daily. Duration: Not to be given >2 days.
Contraindications
Hypersensitivity to diclofenac, aspirin or other NSAIDs, Na metabisulphite, benzyl alcohol, propylene glycol, mannitol. History of active or suspected GI ulcers or bleeding; history of haemorrhagic diathesis, confirmed or suspected cerebrovascular bleeding; operations associated w/ high risk of haemorrhage; history of asthma. Hypovolaemia or dehydration. Concomitant use w/ anticoagulant (including low dose heparin). Moderate to severe renal impairment (serum creatinine >160 mol/L).
Special Precautions
Discontinue use at 1st appearance of skin rash or other sign of hypersensitivity or if GI bleeding or ulceration occurs. GI disorders, history of GI ulceration, ulcerative colitis or Crohn's disease; history of serious GI events, smoking, alcoholism. Increased risk of serious CV events eg, MI; patients w/ CV disease or risk of CV event; HTN; fluid retention or heart failure. Exfoliative dermatitis, toxic epidermal necrolysis, Stevens-Johnson syndrome. May mask signs & symptoms of infection. Concurrent use of aspirin. Severe hepatic impairment. Not recommended during pregnancy & lactation. Not suitable for childn. Elderly.
Adverse Reactions
Headache, dizziness or vertigo; epigastric pain, other GI disorders; rashes, skin eruptions; serum aminotransferase enzymes elevations; local pain & induration.
Drug Interactions
Hypoglycaemic & hyperglycaemic effects w/ oral antidiabetic agents. Increased risk of haemorrhage w/ anticoagulant therapy. Increased plasma conc of lithium & digoxin. Impaired renal excretion w/ methotrexate. Nephrotoxicity w/ cyclosporin. Increased risk of GI bleeding w/ aspirin or corticosteroids. Convulsions w/ quinolones. Increased serum K levels w/ K-sparing diuretics. Exacerbated cardiac failure, reduced GFR & increased plasma glycoside levels w/ cardiac glycosides. Decreased effect of antihypertensives eg, β-blockers, ACE inhibitors, diuretics. Reduced mifepristone effect.
ATC Classification
M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Presentation/Packing
Form
Dicloran Injection soln for inj 25 mg/mL
Packing/Price
3 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in